Bilirubin release induced by tumor necrosis factor in combination with galactosamine is toxic to mice

Cytokine

Volumn 23, Issue 3, 2003, Pages 94-100

  Van Molle, W ^a   Libert, C ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Bilirubin; Galactosamine; Liver; Toxicity; Tumor necrosis factor

Indexed keywords

BILIRUBIN; GALACTOSAMINE; HEME OXYGENASE 1; OXYGENASE INHIBITOR; PROTOPORPHYRIN TIN; PROTOPORPHYRIN ZINC; TUMOR NECROSIS FACTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CORRELATION ANALYSIS; DRUG EFFECT; LIVER CELL; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0043169361     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00203-5     Document Type: Article

References (44)

1. Maines M.D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2:1988;2557-2568.
2. Tenhunen R., Marver H.S., Schmid R. The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med. 75:1970;410-421.
3. Bissell D.M., Hammaker L., Schmid R. Liver sinusoidal cells. Identification of a subpopulation for erythrocyte catabolism. J Cell Biol. 54:1972;107-119.
4. Colleran E., O'Carra P. Enzymology and comparative physiology of biliverdin reduction. Berk P.D., Berlin N.I. International symposium on chemistry and physiology of bile pigments. 1977;69-85 Department of Health, Education and Welfare, Washington, DC.
5. Dutton G.J. Variations in glucuronide formation by perinatal liver. Biochem Pharmacol. 15:1966;947-951.
6. Roy Chowdhurry J., Roy Chowdhurry N., Arias I.M. Bilirubin conjugates in the spiny dogfish, Squalus acanthias, the small skate, Raja erinacea and the winter founder Pseudopleuronectes americanus. Comp Biochem Physiol. 66B:1980;523-528.
7. Majumdar A.P. Bilirubin encephalopathy: effect on RNA polymerase activity and chromatin template activity in the brain of the Gunn rat. Neurobiology. 4:1974;425-431.
8. Katoh R., Kashiwamata S., Niwa F. Studies on cellular toxicity of bilirubin. Effect on the carbohydrate metabolism in the young rat brain. Brain Res. 83:1975;81-86.
9. Nandi Majumdar A.P., Greenfield S. Evidence of defective protein synthesis in liver in rats with congenital hyperbilirubinemia. Biochim Biophys Acta. 335:1974;250-257.
10. Odell G.B. The dissociation of bilirubin from albumin and its clinical implications. J Pediatr. 55:1959;268-273.
11. Leist M., Gantner F., Bohlinger I., Germann P.G., Tiegs G., Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol. 153:1994;1778-1788.
12. 1-acid glycoprotein against tumor necrosis factor-induced lethality. J Exp Med. 180:1994;1571-1575.
13. Leist M., Gantner F., Jilg S., Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol. 154:1995;1307-1316.
14. 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J Immunol. 159:1997;3555-3564.
15. Van Molle W., Denecker G., Rodriguez I., Brouckaert P., Vandenabeele P., Libert C. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol. 163:1999;5235-5241.
16. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 10:2003;45-65.
17. Aggarwal B.B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw. 7:1996;93-124.
18. Tartaglia L.A., Goeddel D.V. Two TNF receptors. Immunol Today. 13:1992;151-153.
19. Beyaert R., Fiers W. Tumor necrosis factor and lymphotoxin. Mire-Sluis A.R., Thorpe R. Cytokines. 1998;335-360 Academic Press, San Diego.
20. Declercq W., Denecker G., Fiers W., Vandenabeele P. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J Immunol. 161:1998;390-399.
21. Tracey K.J., Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 9:1993;317-343.
22. Decker K., Keppler D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol. 71:1974;77-106.
23. Le Moine O., Soupison T., Sogni P., Marchant A., Moreau R., Hadengue A., et al. Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis. J Hepatol. 23:1995;391-395.
24. Su F., Schneider R.J. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α Proc Natl Acad Sci U S A. 94:1997;8744-8749.
25. Fraker D.L., Stovroff M.C., Merino M.J., Norton J.A. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med. 168:1988;95-105.
26. Sanchez-Cantu L., Rode H.N., Christou N.V. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg. 124:1989;1432-1435.
27. Agarwal A., Balla J., Alam J., Croatt A.J., Nath K.A. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int. 48:1995;1298-1307.
28. Shiraishi F., Curtis L.M., Truong L., Poss K., Visner G.A., Madsen K., et al. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol. 278:2000;F726-F736.
29. Otterbein L., Chin B.Y., Otterbein S.L., Lowe V.C., Fessler H.E., Choi A.M. Mechanism of hemoglobin-induced protection against endotoxemia in rats: a ferritin-independent pathway. Am J Physiol. 272:1997;L268-L275.
30. Petrache I., Otterbein L.E., Alam J., Wiegand G.W., Choi A.M. Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol. 278:2000;L312-L319.
31. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1046.
32. Crigler J.F., Najjar V.A. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics. 23:1952;169-179.
33. Childs B., Najjar V.A. Familial nonhemolytic jaundice with kernicterus: a report of two cases without neurologic damage. Pediatrics. 18:1956;369-377.
34. Childs B., Sidbury B., Migeon C.J. Glucuronic acid conjugation by patients with familial non-hemolytic jaundice and their relatives. Pediatrics. 18:1959;903-913.
35. Apstein M.D. Inhibition of biliary phospholipid and cholesterol secretion by bilirubin in the Sprague-Dawley and Gunn rat. Gastroenterology. 87:1984;634-638.
36. Garcia-Marin J.J., Esteller A. Biliary inter-relationship between phospholipid, bilirubin and taurocholate in the anaesthetized rat. Clin Sci. 67:1984;499-504.
37. Veel T., Villanger O., Holthe M.R., Skjorten F.S., Raeder M.G. Intravenous bilirubin infusion causes vacuolization of the cytoplasm of hepatocytes and canalicular cholestasis. Acta Physiol Scand. 143:1991;421-429.
38. Silva R.F., Rodrigues C.M., Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J Hepatol. 34:2001;402-408.
39. Terry C.M., Clikeman J.A., Hoidal J.R., Callahan K.S. Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. Am J Physiol. 274:1998;H883-H891.
40. 2+, and phospholipase A2 in endothelial cells. Am J Physiol. 276:1999;H1493-H1501.
41. Libert C., Van Molle W., Brouckaert P., Fiers W. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality. J Inflamm. 46:1996;139-143.
42. Van Molle W., Vanden Berghe J., Brouckaert P., Libert C. Tumor necrosis factor-induced lethal hepatitis: Pharmacological intervention with verapamil, tannic acid, picotamide and K76COOH. FEBS Lett. 467:2000;201-205.
43. Wielockx B., Lannoy K., Shapiro S.D., Itoh T., Itohara S., Vandekerckhove J., et al. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med. 7:2001;1202-1208.
44. Wielockx B., Bussolino F., Shapiro S.D., Libert C. Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. J Hepatol. 35:2001;490-497.